For example, Han et al. [126] showed that pretreatment with TGF-β prior to oncolytic virus (OV) therapy effectively inhibited tumor growth by suppressing resident microglia and natural killer (NK) cells in glioblastoma therapy trial. The gene discussed is TGFB1; the disease is neoplasm.